A Phase I/II trial to evaluate the safety, immunogenicity, and clinical activity of a helper peptide vaccine plus CTLA-4 blockade in Advanced Melanoma (Mel62; 6PAC)

IRB/UVA Tracking #
17780
Contact First Name

Jessica Zareno

Contact Email
Contact Phone
Phase
I/II
Primary purpose
Treatment
Cancer PI
Elizabeth M Gaughan
Status
OPEN TO ACCRUAL